Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Revenio Group Oyj's share price for the quarter that ended in Mar. 2024 was $28.35. Revenio Group Oyj's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 26.6 Mil. Therefore, Revenio Group Oyj's market cap for the quarter that ended in Mar. 2024 was $753.9 Mil.
Revenio Group Oyj's quarterly market cap
stayed the same
from Sep. 2023 ($1,170.1 Mil) to Dec. 2023 ($1,170.1 Mil) but then
declined
from Dec. 2023 ($1,170.1 Mil) to Mar. 2024 ($753.9 Mil).
Revenio Group Oyj's annual market cap
declined
from Dec. 2021 ($2,005.5 Mil) to Dec. 2022 ($1,169.5 Mil) but then
increased
from Dec. 2022 ($1,169.5 Mil) to Dec. 2023 ($1,170.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Revenio Group Oyj's Enterprise Value for Today is $761.9 Mil.
Revenio Group Oyj Market Cap Historical Data
The historical data trend for Revenio Group Oyj's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Revenio Group Oyj's Market Cap
For the Medical Devices subindustry, Revenio Group Oyj's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Market Cap distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's Market Cap falls into.
Revenio Group Oyj Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Revenio Group Oyj's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (OTCPK:REVXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Revenio Group Oyj Market Cap Related Terms
Thank you for viewing the detailed overview of Revenio Group Oyj's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Revenio Group Oyj (Revenio Group Oyj) Business Description
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
REVXF has been successfully added to your 